Advances in diagnosis and management of cancer of the esophagus

N Deboever, CM Jones, K Yamashita, JA Ajani… - bmj, 2024 - bmj.com
Esophageal cancer is the seventh most common malignancy worldwide, with over 470 000
new cases diagnosed each year. Two distinct histological subtypes predominate, and …

Detection of tumour-targeted IRDye800CW tracer with commercially available laparoscopic surgical systems

DJ Sikkenk, AJ Sterkenburg, I Schmidt, D Gorpas… - Diagnostics, 2023 - mdpi.com
(1) Introduction: Near-infrared fluorescence (NIRF) combined with tumour-targeted tracers,
such as bevacizumab-800CW, could aid surgical decision-making. This study explored the …

Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease

RY Gabriëls, AM van der Waaij, MD Linssen, M Dobosz… - Gut, 2024 - gut.bmj.com
Objective Improving patient selection and development of biological therapies such as
vedolizumab in IBD requires a thorough understanding of the mechanism of action and …

PARP1-targeted fluorescence molecular endoscopy as novel tool for early detection of esophageal dysplasia and adenocarcinoma

S Marcazzan, MJ Braz Carvalho, NT Nguyen… - Journal of Experimental …, 2024 - Springer
Background Esophageal cancer is one of the 10 most common cancers worldwide and its
incidence is dramatically increasing. Despite some improvements, the current surveillance …

Performance Assessment and Quality Control of Fluorescence Molecular Endoscopy with a Multi-Parametric Rigid Standard

A Tenditnaya, RY Gabriëls… - … on Medical Imaging, 2024 - ieeexplore.ieee.org
Fluorescence molecular endoscopy (FME) is emerging as a “red-flag” technique with
potential to deliver earlier, faster, and more personalized detection of disease in the …